AR099870A1 - Derivados de 4,5-dihidro-1h-pirazol-3-carboximidamida que contienen grupos azufre, método para prepararlos, y composición farmacéutica que los comprende - Google Patents

Derivados de 4,5-dihidro-1h-pirazol-3-carboximidamida que contienen grupos azufre, método para prepararlos, y composición farmacéutica que los comprende

Info

Publication number
AR099870A1
AR099870A1 ARP150100918A ARP150100918A AR099870A1 AR 099870 A1 AR099870 A1 AR 099870A1 AR P150100918 A ARP150100918 A AR P150100918A AR P150100918 A ARP150100918 A AR P150100918A AR 099870 A1 AR099870 A1 AR 099870A1
Authority
AR
Argentina
Prior art keywords
alkyl
obesity
carboximidamide
activity
preparing
Prior art date
Application number
ARP150100918A
Other languages
English (en)
Spanish (es)
Inventor
Hyun Suh Kwee
Jin Hong Dong
Hee Ha Tae
Ouk Baek Jong
Sook Oh Hee
Sub Lee Moon
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of AR099870A1 publication Critical patent/AR099870A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP150100918A 2014-03-31 2015-03-27 Derivados de 4,5-dihidro-1h-pirazol-3-carboximidamida que contienen grupos azufre, método para prepararlos, y composición farmacéutica que los comprende AR099870A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140038258A KR20150113762A (ko) 2014-03-31 2014-03-31 황 작용기를 포함하는 4,5-다이하이드로-1h-피라졸-3-카복스이미드아마이드 유도체, 이의 제조방법 및 이를 포함하는 약학 조성물

Publications (1)

Publication Number Publication Date
AR099870A1 true AR099870A1 (es) 2016-08-24

Family

ID=54240811

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150100918A AR099870A1 (es) 2014-03-31 2015-03-27 Derivados de 4,5-dihidro-1h-pirazol-3-carboximidamida que contienen grupos azufre, método para prepararlos, y composición farmacéutica que los comprende

Country Status (4)

Country Link
KR (1) KR20150113762A (zh)
AR (1) AR099870A1 (zh)
TW (1) TW201623244A (zh)
WO (1) WO2015152550A1 (zh)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008517976A (ja) * 2004-10-25 2008-05-29 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ１カンナビノイド受容体拮抗薬及びカリウムチャンネルオープナーから成る、真性糖尿病１型、肥満及び関連症状の治療用の医薬組成物
US20070254863A1 (en) * 2006-04-27 2007-11-01 Jochen Antel Use of CBx cannabinoid receptor modulators as potassium channel modulators
US7763607B2 (en) * 2006-04-27 2010-07-27 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
AR071487A1 (es) * 2008-04-23 2010-06-23 Solvay Pharm Bv Derivados de (5r)-1,5-diaril-4,5-dihidro-1h-pirazol-3-carboxamidina que tienen actividad antagonista cb1

Also Published As

Publication number Publication date
TW201623244A (zh) 2016-07-01
KR20150113762A (ko) 2015-10-08
WO2015152550A1 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
ECSP18094790A (es) Piridinas sustituidas con heteroarilo y métodos de uso referencia cruzada a solicitudes relacionadas
CO2019000386A2 (es) Compuestos heterocíclicos como inmunomoduladores
CL2018001685A1 (es) Compuestos heterociclicos como inmuno moduladores.
CL2019001744A1 (es) Derivados de benzoxazol como inmunomoduladores.
NZ747259A (en) Soluble c5ar antagonists
CU20160087A7 (es) Indazolcarboxamidas, procedimientos para su preparación, preparaciones farmacéuticas que las contienen
ECSP17021897A (es) Compuestos y composiciones como inhibidores de quinasa raf
UY37073A (es) Salicilamidas espiroheptanos y compuestos relacionados como inhibidores de rock, y las composiciones que los contienen
CO2017012566A2 (es) Piridinas sustituidas y método de uso
CO2020000056A2 (es) Nuevos compuestos y composiciones farmacéuticas de los mismos para el tratamiento de la fibrosis
CR20160321A (es) Modulares de tetrahidropiridopirazinas de gpr6
MD4626C1 (ro) Derivaţi de tamoxifen pentru tratamentul afecţiunilor neoplazice, în special cu nivel înalt de proteină HER2
UY35906A (es) Novedosos derivados de bencimidazol como ligandos de ep4
CO2017007325A2 (es) 2,4 diamino-quinolina sustituida como nuevos agentes anti-cancerigenos
UY37442A (es) Derivados de fenilamina 4-sustituidos y su uso para proteger cultivos al combatir microorganismos fitopatogénicos indeseados
EA201791058A1 (ru) Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4)
UY35997A (es) Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
AR090879A1 (es) Acidos indanoiloxidihidrobenzofuranilaceticos
DOP2020000118A (es) Proceso para la preparación de derivados de quinolina
SV2016005310A (es) Derivados de diheterociclo enlazado a cicloalquilo
DOP2016000211A (es) Pirazinas moduladoras de gpr6
AR099870A1 (es) Derivados de 4,5-dihidro-1h-pirazol-3-carboximidamida que contienen grupos azufre, método para prepararlos, y composición farmacéutica que los comprende
AR100420A1 (es) Derivados bicíclicos y composición farmacéutica que los incluye
BR112017027371A2 (pt) novos antagonistas 5-ht2
AR101053A1 (es) Derivados de 1,5-diaril-4,5-dihidro-1h-pirazol-3-carboxamidina como antagonista del receptor cb1 de canabinoides, método para su preparación, y composición farmacéutica que comprende el mismo

Legal Events

Date Code Title Description
FB Suspension of granting procedure